Assistant Professor, Internal Medicine, Washington University School of Medicine
Cardiology
Dr. Sharon Cresci, MD
|
|
Give Review
Sharon Cresci, MD practices Cardiology. She graduated from NYU School of Medicine. She over the years received 1 awards: "Fellow (FACC)". Sharon Cresci, MD is a published MD as well. She has 36 publications published. The latest was: Utility of a genetic risk score to predict recurrent cardiovascular events 1 year after an acute coronary syndrome: A pooled analysis of the RISCA, PRAXY, and TRIUMPH ... She is registered with Medicare.
Publications
- Utility of a genetic risk score to predict recurrent cardiovascular events 1 year after an Acute coronary syndrome: A pooled analysis of the RISCA, PRAXY, and TRIUMPH ...
- Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for Myocardial infarction.
- Clinical outcomes associated with proton pump inhibitor use among clopidogrel-treated patients within CYP2C19 genotype groups following Acute myocardial infarction.
- CHRNA5 Variant Predicts Smoking Cessation in Patients With Acute Myocardial Infarction.
- Cytochrome P450 Gene Variants, Race, and Mortality Among Clopidogrel Treated Patients Following Acute Myocardial Infarction.
- Association between diabetes mellitus and Angina after acute myocardial infarction: analysis of the TRIUMPH prospective cohort study.
- Insulin Resistance Is Associated With Significant Clinical Atherosclerosis in Nondiabetic Patients With Acute Myocardial Infarction.
- Hemodynamic manifestations of ischemic right Heart dysfunction.
- Frequency of compound genotypes associated with beta-blocker efficacy in congestive Heart failure.
- Genotypes associated with Myocardial infarction risk are more common in African Americans than in European Americans.
- Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an Acute coronary syndrome.
- The PPAR genes, cardiovascular Disease and the emergence of PPAR pharmacogenetics.
- Image-guided cardiovascular functional genomics: finding the needle in the haystack.
- Connexin37 (GJA4) genotype predicts survival after an Acute coronary syndrome.
- Pharmacogenetics of the PPAR genes and cardiovascular Disease.
- From SNPs to functional studies in cardiovascular pharmacogenomics.
- PPAR Genomics and Pharmacogenomics: Implications for Cardiovascular Disease.
- A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in Heart failure.
- The mechanistic imperative for pharmacogenomics.
- Epithelial neutrophil-activating peptide (ENA-78), Acute coronary syndrome prognosis, and modulatory effect of statins.
- Interaction between PPARA genotype and beta-blocker treatment influences clinical outcomes following Acute coronary syndromes.
- PPAR transcriptional activator complex polymorphisms and the promise of individualized therapy for Heart failure.
- PGC-1alpha and ERRalpha target gene downregulation is a signature of the failing human Heart.
- Genome-wide association studies of coronary artery disease and Heart failure: where are we going?
- Clinical and genetic modifiers of long-term survival in Heart failure.
- Common variants in HSPB7 and FRMD4B associated with advanced Heart failure.
- Interaction between the UCP2 -866 G>A polymorphism, diabetes, and beta-blocker use among patients with Acute coronary syndromes.
- Echocardiographic tissue characterization demonstrates differences in the left and right sides of the ventricular septum.
- A PPAR? promoter variant impairs ERR-dependent transactivation and decreases mortality after Acute coronary ischemia in patients with diabetes.
- Aromatase gene polymorphisms are associated with survival among patients with cardiovascular Disease in a sex-specific manner.
- Chromosome 9p21 haplotypes and prognosis in white and black patients with Coronary artery disease.
- Factors influencing patient willingness to participate in genetic research after a Myocardial infarction.
- Peroxisome proliferator-activated receptor pathway gene polymorphism associated with extent of Coronary artery disease in patients with type 2 diabetes in the bypass a...
- Investigation of 95 variants identified in a genome-wide study for association with mortality after Acute coronary syndrome.
- ADRB1 variants in atrial fibrillation: small steps and giant leaps toward personalized therapy in cardiovascular Disease.
Schools
New York University
New York University School Of Med
Washington University
Procedures Preformed
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac Myocardial Perfusion Imaging
- Cardioversion, Elective
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Valve Disease
- Arrhythmias (incl. Atrial Fibrillation)
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- Fellow (FACC)
Education
-
Washington University - Barnes-Jewish Hospital -
NYU School of Medicine
Hospital
-
Barnes-Jewish Hospital
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1083630214 |
| Last Name Of The Provider | CRESCI |
| First Name Of The Provider | SHARON |
| View All |
Similar Doctors
|
Dr. Robert B. Lehman, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jane Chen, MD |
|
|
Dr. Mitchell N. Faddis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bassam N. Al-Joundi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul H. Gibson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John W. Kilgore, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ronald N. Riner, MD |
|
|
Dr. Susan M. Joseph, MD |
|
|
Dr. Linda R. Peterson, MD
This Doctor is OpenDoctor Recommended.
|